Would New Drug Launches Speed Up With A Pan-Asia Regulatory Framework? - Biopharma Asia Conference
This article was originally published in PharmAsia News
Executive Summary
SINGAPORE - As diseases like diabetes and cardiovascular complications - previously believed to be more prevalent in Western nations - are progressively spreading East to places like India and China, Asia-based pharmaceutical companies are pushing for a pan-Asian regulatory regime that can benefit its people with clear and obtainable goals